Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > ONC the promise that never fulfills

<< Previous

Bullboard Posts

Next >>

Comment by GOBOGOHon Feb 17, 2021 2:50pm

166 Views

Post# 32586719

RE:RE:ONC the promise that never fulfills

Westcoast,

I know the examples are not the same - I referencing timeframes - ONC has been around a lot longer then 3 years and the big break through was supposed to happen yours ago. Maybe it will happen now, maybe not. Their track record is not impressive in terms of stock performance - the reverse split didn't help the shareholder. But, this could just be sour grapes on my part, tend to get a little irritable when I down $20K.

<< Previous

Bullboard Posts

Next >>

The Market Online’s Weekly Cannabis Report – Nov. 22, 2024